Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common stock, par value $0.00001
-
Shares outstanding
-
43,754,363
-
Total 13F shares
-
1,458,347
-
Share change
-
-119,753
-
Total reported value
-
$3,849,839
-
Price per share
-
$2.64
-
Number of holders
-
20
-
Value change
-
-$264,705
-
Number of buys
-
10
-
Number of sells
-
7
Institutional Holders of Cellectar Biosciences, Inc. - Common stock, par value $0.00001 (CLRB) as of Q3 2023
As of 30 Sep 2023,
Cellectar Biosciences, Inc. - Common stock, par value $0.00001 (CLRB) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,458,347 shares.
The largest 10 holders included
AIGH Capital Management LLC, Worth Venture Partners, LLC, VANGUARD GROUP INC, ACUTA CAPITAL PARTNERS, LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, MORGAN STANLEY, and WEALTH ENHANCEMENT ADVISORY SERVICES, LLC.
This page lists
20
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.